(Q28196501)

English

Role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors, angiotensin-converting enzyme inhibitors, cyclooxygenase-2 inhibitors, and aspirin in anti-inflammatory and immunomodulatory treatment of cardiovascular diseases

scientific article (publication date: 19 June 2003)

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818730%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

Europe PubMed Central

Role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors, angiotensin-converting enzyme inhibitors, cyclooxygenase-2 inhibitors, and aspirin in anti-inflammatory and immunomodulatory treatment of cardiovascular diseases (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818730%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

based on heuristic

inferred from title

author name string

Bernhard Schieffer

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818730%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Helmut Drexler

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818730%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818730%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818730%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

91

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818730%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

12A

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818730%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

12H-18H

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818730%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

An Account of the Success of the Bark of the Willow in the Cure of Agues. In a Letter to the Right Honourable George Earl of Macclesfield, President of R. S. from the Rev. Mr. Edmund Stone, of Chipping-Norton in Oxfordshire

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Pharmakologisches über Aspirin (Acetylsalicylsäure)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Aspirin protects low density lipoprotein from oxidative modification

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Indomethacin enhances endothelial NO release--evidence for a role of PGI2 in the autocrine control of calcium-dependent autacoid production

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Aspirin improves endothelial dysfunction in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Salicylate is a transcriptional inhibitor of the inducible nitric oxide synthase in cultured cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Effect of acetylsalicylic acid on nitric oxide production in infarcted heart in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

In vitro antioxidant properties of potential biotransformation products of salicylate, sulphasalazine and amidopyrine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

In vitro Acetylation of Plasma Proteins, Enzymes and DNA by Aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

An Overview of the British and American Aspirin Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Clinical pharmacology of platelet cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: the Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 (NUT-2) pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Regulation of the mevalonate pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Statins as a newly recognized type of immunomodulator

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Effects of statins on inflammation in patients with acute and chronic coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Effect of pravastatin on outcomes after cardiac transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Interactions among ACE, kinins and NO.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Angiotensin II type 2 receptors: signalling and pathophysiological role

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Angiotensin induces inflammatory activation of human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Increased angiotensin-converting enzyme activity in coronary artery specimens from patients with acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Evidence that macrophages in atherosclerotic lesions contain angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Elevated Levels of Interleukin-6 in Unstable Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Acute coronary syndromes: biology

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900429-6

7 January 2021

Identifiers

10.1016/S0002-9149(03)00429-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818730%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818730%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28196501&oldid=1374680476"